Boiron SA (BOIR.PA)
BOIR.PA on Paris Stock Exchange
37.35EUR
16 Aug 2019
37.35EUR
16 Aug 2019
Change (% chg)
€1.25 (+3.46%)
€1.25 (+3.46%)
Prev Close
€36.10
€36.10
Open
€36.00
€36.00
Day's High
€37.85
€37.85
Day's Low
€36.00
€36.00
Volume
7,896
7,896
Avg. Vol
11,768
11,768
52-wk High
€69.00
€69.00
52-wk Low
€34.30
€34.30
About
Boiron SA is a France-based pharmaceutical company engaged in the provision of homeopathic medicines. The Company develops, manufactures and markets single homeopathic medicines and drugs which are in the form of tablets, syrups, single-dose liquids and ointments. It also produces medicines based on trace elements, phytotherapy... (more)
Overall
| Beta: | 0.86 |
| Market Cap(Mil.): | €696.47 |
| Shares Outstanding(Mil.): | 17.57 |
| Dividend: | 1.45 |
| Yield (%): | 4.04 |
Financials
| BOIR.PA | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 12.23 | 29.73 | 33.85 |
| EPS (TTM): | 3.24 | -- | -- |
| ROI: | 9.24 | 13.04 | 12.69 |
| ROE: | 11.45 | 14.12 | 17.13 |
BRIEF-Boiron: HAS Maintains Unfavorable Opinion Regarding Reimbursement Of Homeopathic Medicines
* HAUTE AUTORITE DE SANTE (HAS) HAS MAINTAINED ITS UNFAVORABLE OPINION REGARDING THE REIMBURSEMENT OF HOMEOPATHIC MEDICINES
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.✕
Estimates